POU2F1 and neoplasm: Additionally, by recognizing the CDX2 promoter, OCT1 is thought to boost malignancy of both pancreatic and intestine cell lines [19], and studies on p53-deficient mice revealed that dysfunction of OCT1 restrains in vitro tumor transformation and in vivo tumorigenicity via metabolic procedure shift [20].